Article in Platelets, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors at 3 institutions in 2 countries.
Jason CunhaNational Heart, Lung and Blood Institute's the Framingham Heart Study, Boston University and National Heart, Framingham, MA, USA.ORCID 0009-0005-7909-8809
Melissa V ChanNational Heart, Lung and Blood Institute's the Framingham Heart Study, Boston University and National Heart, Framingham, MA, USA.ORCID 0000-0003-2154-1386
Bongani B NkambuleNational Heart, Lung and Blood Institute's the Framingham Heart Study, Boston University and National Heart, Framingham, MA, USA.ORCID 0000-0001-8846-1992
Florian ThibordNational Heart, Lung and Blood Institute's the Framingham Heart Study, Boston University and National Heart, Framingham, MA, USA.ORCID 0000-0003-2229-8322
Amber LachapelleNational Heart, Lung and Blood Institute's the Framingham Heart Study, Boston University and National Heart, Framingham, MA, USA.
Robin E PashekNational Heart, Lung and Blood Institute's the Framingham Heart Study, Boston University and National Heart, Framingham, MA, USA.
Ramachandran S VasanNational Heart, Lung and Blood Institute's the Framingham Heart Study, Boston University and National Heart, Framingham, MA, USA.ORCID 0000-0001-7357-5970
Jian RongNational Heart, Lung and Blood Institute's the Framingham Heart Study, Boston University and National Heart, Framingham, MA, USA.
Emelia J BenjaminNational Heart, Lung and Blood Institute's the Framingham Heart Study, Boston University and National Heart, Framingham, MA, USA.ORCID 0000-0003-4076-2336
Naomi M HamburgWhitaker Cardiovascular Institute, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.ORCID 0000-0001-5504-5589
Ming-Huei ChenNational Heart, Lung and Blood Institute's the Framingham Heart Study, Boston University and National Heart, Framingham, MA, USA.ORCID 0000-0003-3551-8726
Gary F MitchellCardiovascular Engineering, Inc, Norwood, MA, USA.
Andrew D JohnsonNational Heart, Lung and Blood Institute's the Framingham Heart Study, Boston University and National Heart, Framingham, MA, USA.ORCID 0000-0001-6369-5178
National Heart Lung and Blood Institute · USBoston University · USNorwood Hospital · US
Funding
FRAMINGHAM HEART STUDY - YEAR 5 EXAM75N92019D00031 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · 2019 to 2024
$29.8M
Cardiovascular Genomics and Bioinformatics projectsZIAHL006170 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI JOHNSON, ANDREW · 2013 to 2025
$25.3M
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVALR01HL092577 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI BENJAMIN, EMELIA J., ELLINOR, PATRICK THOMAS · 2009 to 2025
$20.6M
Cardiac microstructure and the immune-inflammatory response to SARS-CoV-2R01HL131532 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI CHENG, SUSAN, LI, DEBIAO · 2016 to 2025
$6.6M
Mediators of Systemic Inflammation and Heart Failure Risk in the CommunityR01HL143227 · NHLBI · CEDARS-SINAI MEDICAL CENTER · PI CHENG, SUSAN · 2019 to 2022
$3.3M
Ventricular-vascular coupling in the elderly: lifecourse determinants, trajectories, and prognostic significanceR01HL142983 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI CHENG, SUSAN, MITCHELL, GARY FRANK · 2019 to 2022
$3.2M
Vascular Stiffness as a Precursor of Hypertension in a Middle-aged CohortR01HL126136 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MITCHELL, GARY FRANK, RAMACHANDRAN, VASAN S · 2015 to 2018
$2.6M
Aortic Dysfunction, Pulsatile Stress and Target Organ Damage in FraminghamR01HL107385 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MITCHELL, GARY FRANK, RAMACHANDRAN, VASAN S · 2011 to 2014
$2.6M
Genome-wide Association Study of Cardiac Structure and FunctionR01HL093328 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI RAMACHANDRAN, VASAN S · 2008 to 2011
$2.4M
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
Arterial tonometry and vascular calcification measures are useful in cardiovascular disease (CVD) risk assessment. Prior studies found associations between tonometry measures, arterial calcium, and CVD risk. Activated platelets release angiopoietin-1 and other factors, which may connect vascular structure and platelet function. We analyzed arterial tonometry, platelet function, aortic, thoracic and coronary calcium, and thoracic and abdominal aorta diameters measured in the Framingham Heart Study Gen3/NOS/OMNI-2 cohorts (
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Trends among platelet function, arterial calcium, and vascular function measures. · full record | OpenQuestion